| Product Code: ETC12962847 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of naltrexone and buprenorphine to Estonia in 2024 continued to see a steady increase, with top exporting countries being Germany, Lithuania, Italy, Slovenia, and Belgium. Despite the growth, the market remains competitive with a very low concentration level, as indicated by the low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 8.49%, while the growth rate from 2023 to 2024 stood at an impressive 9.4%, reflecting a strong upward trajectory for these pharmaceutical imports in Estonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Naltrexone Buprenorphine Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Estonia Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Estonia Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Estonia Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Estonia Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 Estonia Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Estonia Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of using naltrexone and buprenorphine for addiction treatment |
4.2.2 Growing prevalence of substance abuse and addiction issues in Estonia |
4.2.3 Rising government initiatives to address the opioid crisis and promote the use of medication-assisted treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for naltrexone and buprenorphine products |
4.3.2 Limited availability of specialized healthcare professionals trained in prescribing and managing naltrexone and buprenorphine treatments |
5 Estonia Naltrexone Buprenorphine Market Trends |
6 Estonia Naltrexone Buprenorphine Market, By Types |
6.1 Estonia Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 Estonia Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 Estonia Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 Estonia Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Estonia Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 Estonia Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 Estonia Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Estonia Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Estonia Naltrexone Buprenorphine Market Imports from Major Countries |
8 Estonia Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering naltrexone and buprenorphine treatments |
8.2 Percentage increase in the number of patients receiving naltrexone and buprenorphine therapy |
8.3 Rate of prescription of naltrexone and buprenorphine compared to traditional addiction treatments |
9 Estonia Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Estonia Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 Estonia Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Estonia Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Estonia Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 Estonia Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 Estonia Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Estonia Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Estonia Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here